Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…

Biotechnology

US, Boston [HQ]

Overview
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More

News

Theses · Events · Sentiments

Articles

24-11-13

Vertex Pharmaceuticals' Potential Breakthrough and Market Position

Vertex Pharmaceuticals (NASDAQ:VRTX) receives a "Buy" rating from Citigroup amidst a potential drug …

Sentiments

24-11-13 0.00%

Regulators are reviewing what could become a multi-billion-dollar drug.

24-10-25 0.00%

This stock might not be available for under $500 for long.